Sign up to save your podcasts
Or
Share Morgan Stanley Reports Strong Results As Dealmaking Strengthens
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Morgan Stanley Reports Strong Results As Dealmaking Strengthens
Plus: Novavax says the FDA rejected its combination Covid-19 and flu vaccine because of a “serious adverse event” in a clinical-trial participant. Elon Musk’s SpaceX sues California regulators for voting down a request to allow more of the company’s rocket launches there. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By The Wall Street Journal
4.2
652652 ratings
Plus: Novavax says the FDA rejected its combination Covid-19 and flu vaccine because of a “serious adverse event” in a clinical-trial participant. Elon Musk’s SpaceX sues California regulators for voting down a request to allow more of the company’s rocket launches there. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like WSJ Minute Briefing
View all
WSJ Opinion: Potomac Watch
2,842 Listeners
WSJ Your Money Briefing
1,730 Listeners
WSJ What’s News
4,386 Listeners
Bloomberg Intelligence
412 Listeners
Bloomberg Businessweek
435 Listeners
WSJ Tech News Briefing
1,657 Listeners
Bold Names
1,447 Listeners
Wall Street Breakfast
1,042 Listeners
Thoughts on the Market
1,314 Listeners
The Journal.
6,129 Listeners
Barron's Streetwise
1,583 Listeners
Barron's Live
210 Listeners
Bad Bets
1,323 Listeners
WSJ Opinion: Free Expression
585 Listeners
As We Work
152 Listeners
Bloomberg Daybreak: US Edition
85 Listeners
The Markets
86 Listeners
WSJ's Take On the Week
149 Listeners